odmj OncoDaily Medical Journal ODMJ 3067-6444 OncoDaily Medical Journal US 5792 10.69690/ODMJ-001-1015-5792 Original Research Bridging the Global Divide in Colorectal Cancer Care: Findings from the "Global Cancer Movement - Challenging the Status Quo in Colorectal Cancer" Congress Sargsyan Amalya Head of Intelligence Unit, OncoDaily/ Medical Oncologist, Yeolyan Hematology and Oncology Center/ Clinical Research Physician, Immune Oncology Research Institute, Armenia amalyasargsyan@gmail.com Ilbawi Andre Team lead, Cancer Control, Department of Noncommunicable Diseases and Mental Health, World Health Organization, Switzerland Margaryan Yeva Managing Editor, CancerWorld Yacoubian Jack Yerevan State Medical University Jumanov Abay Head of Surgery Department, Kazakh Institute of Oncology and Radiology (KazIOr), Kazakhstan Pogacian Adrian Psycho-Oncologist, Founder, INCKA Psycho-oncology Center Kazaryan Airazat M. Consultant Surgeon, Department of Gastrointestinal Surgery, Østfold Hospital Trust/ Honorary Researcher, Interventional Centre, Oslo University Hospital/ Visiting Professor, Yerevan State Medical University, Armenia Aggarwal Ajay Professor of Cancer Services and Systems Research, King’s College London/ Consultant Clinical Oncologist, Guy’s and St Thomas’ NHS Trust/ Co-chair, HERO Group, ESTRO, UK Družić Amil Oncology and Radiotherapy Resident, Clinical Centre University of Sarajevo – Oncology Clinic/ Young Cancer Professional, European Cancer Organisation, Bosnia and Herzegovina Suleymanova Amina Pediatric Oncologist and Senior Scientist, Research Institute of Pediatric Oncology and Hematology of N.N. Blokhin National Medical Research Center of Oncology Spiegel Andrew CEO, Global Colon Cancer Association, USA Avagyan Armen Medical Oncologist, Mikayelyan Institute of Surgery, Armenia Laderian Bahar Director, Neuroendocrine Tumors Program, Montefiore Einstein Comprehensive Cancer Center/ Assistant Professor of Medicine and Oncology, Albert Einstein College of Medicine, USA Gyawali Bishal Associate Professor in Medical Oncology and Public Health Sciences, Division of Cancer Care and Epidemiology, Queen’s University/ Co-Leader, Common Sense Oncology Movement, Canada Park Chandler Advisory Dean, Clinical Professor, University of Louisville School of Medicine/ Norton Cancer Institute/ ASCO State Society Tsagkaris Christos Member, EU Cancer Mission Board, Horizon Europe, Brussels, Belgium/ Institute of Cancer and Crisis, Yerevan, Armenia/ Aristotle University of Thessaloniki, Faculty of Medicine, Thessaloniki, Greece Parseghian Christine Associate Professor of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, USA Fan Daiming President, China Anti-Cancer Association; President, Asian Oncology Society/ Director and Professor, Xijing Hospital of Digestive Diseases, China Zohrabyan Davit Chief, Clinic of Chemotherapy, Yeolyan Hematology and Oncology Clinic/ ESMO National Representative to Armenia, Armenia Chand Dhan Vice President, Research, Agenus Inc., USA Barnell Erica K. Co-Founder, Chief Medical and Science Officer, Geneoscopy, USA Baloyan Elen Medical Oncology Resident, Yerevan State Medical University/ Managing Editor, OncoDaily Djordjevic Fedja Medical Oncologist, Institute for Oncology and Radiology of Serbia, Serbia Pietrantonio Filippo Head, Gastrointestinal Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Ramshorst Gabrielle H. van Associate Professor, Ghent University/ Consultant Surgical Oncologist, Ghent University Hospital, Ghent, Belgium Kapetanakis George President, Hellenic Cancer Federation – ELLOK, Greece Abou-Alfa Ghassan Professor, Weill Cornell College at Cornell University; Attending, Memorial Sloan Kettering Cancer Center/ Adjunct Professor of Medical Diplomacy, Trinity College Dublin, USA Rasheed Hadi Mohamed Abu Scientific Adviser, Qatar Cancer Society/ Adjunct Lecturer, University of Doha for Science & Technology, Qatar Vardevanyan Hovhannes Chief of Radiology Department, Wigmore Hospital/ Chief of Radiology Department, Armenian-American Wellness Center, Armenia Rawicka Iga President, EuropaColon Polska Foundation, Polandko Arakelyan Jemma CEO, Institute of Cancer and Crisis/ Advisor, Immune Oncology Research Institute Rapanarilala Johanna Medical Oncologist and Head of Oncology Unit, Seychelles Hospital; Ministry of Health, Seychelles Taieb Julien Professor and Head, Gastroenterology and GI Oncology Department, Georges Pompidou European Hospital, Université de Paris, France Soghomonyan Karine Medical Oncologist, National Center of Oncology after Fanarjyan, Armenia Harutyunyan Lilit Chairman, Department of Oncology, Yerevan State Medical University/ Chief, Clinic of Chemotherapy, Mikayelyan Institute of Surgery of YSMU, Armenia Segarmurthy Malar Velli Public Health Physician, Kuala Langat District Health Office, Ministry of Health, Malaysia Shah Manish A. Professor of Medicine, Weill Cornell Medical College/ Bartlett Family Professor, Gastrointestinal Oncology, Weill Cornell Medical College/ Chief, Solid Tumor Oncology, Weill Cornell Medical College Babak Maria V. Head, Drug Discovery Lab, City University of Hong Kong/ Assistant Professor, City University of Hong Kong, China Aapro Matti President, Sharing Progress in Cancer Care (SPCC)/ Chairman of the Editorial Board, OncoDaily Medical Journal/ Past-President, European Cancer Organization, Switzerland Sapienza Michael CEO, Colorectal Cancer Alliance, USA Toledo Mila Ogalla Patient Advocate with a lived CRC Experience/ Board Member and PAC Chair, DiCE/ Member of Youth Cancer Europe, Fight CRC, Inspire 2 Live Mutebi Miriam Consultant Breast Surgical Oncologist, Clinical Epidemiology, Department of Surgery, Aga Khan University Hospital, Nairobi, Kenya/ President, African Organization for Research and Training in Cancer (AORTIC)/ Past President, Kenya Society of Hematology and Oncology (KESHO)/ Board Member, Board of Directors, Union for International Cancer Control(UICC)/ Co-founder, Pan African Women’s Association of Surgeons (PAWAS) Bracken Moy Research Unit Manager, Access to Medicine Foundation, Netherlands Mnatsakanyan Narine Patient Advocate, MBA, MSP, Armenia Jokhadzde Natia Chief of Clinical Oncology Department, American Hospital Tbilisi, Georgi Hammad Nazik Professor and Medical Oncologist, Division of Hematology-Oncology, St. Michael’s Hospital, University of Toronto, Canada Kasi Pashtoon Medical Director of GI Medical Oncology, City of Hope Orange County/ Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research, USA Wysocki Piotr J. Professor and Head, Clinical Oncology Department, Jagiellonian University-Medical College/ Past-President, Polish Society of Clinical Oncology, Poland Guzman Roselle De Medical Oncologist and Associate Professor of Medicine, Manila Central University-FDTMF Hospital, Philippines Tejpar Sabine Professor of Medicine, KU Leuven/ Head of Digestive Oncology, KU Leuven Bardakhchyan Samvel Scientific Director, Immune Oncology Research Institute/ Adjunct Associate Professor, Yerevan State Medical University/ Medical Oncologist, Yeolyan Hematology and Oncology Center, Armenia Al-Sukhun Sana Director, Al Hyatt Oncology Practice; Past President, Jordanian Oncology Society/ Professor, University of Jordan Greer Susanna Chief Scientific Officer, The V Foundation for Cancer Research, USA Kachaamy Toufic Chief of Medicine and Director of Gastroenterology and Endoscopy, City of Hope, Phoenix, USA Oganezova Toma Miqayelyan Institute of Surgery, Armenia Schmidt-Straßburger Uta Scientific Director, Master Online Study Program Advanced Oncology, Ulm University, Germany Vanderpuye Verna National Center for Radiotherapy, Oncology and Nuclear Medicine, Korlebu Teaching Hospital, Accra, Ghana Subbiah Vivek Chief, Early-Phase Drug Development, Sarah Cannon Research Institute, USA Leyfman Yan Department of Hematology Oncology, NewYork Presbyterian Hospital, USA https://orcid.org/0000-0002-2740-9215 Tamamyan Gevorg Editor-in-Chief, OncoDaily/ Chairman and Professor, Department of Hematology and Pediatric Oncology, Yerevan State Medical University/ CEO, Immune Oncology Research Institute, Armenia Janjigian Yelena Chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, USA 15 10 2025 ODMJ-001-1015-5792 Copyright (c) 2025 OncoDaily Medical Journal 2025 OncoDaily Medical Journal Cancer Screening Cancer Treatment colorectal cancer Early Detection Early-Age Onset Colorectal Cancer Global Cancer Movement Global Health Health Disparities Health Policy low and middle-income countries Patient Advocacy production-ready-file-url Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338–44. Colorectal cancer [Internet]. World Health Organization; [cited 2025 Jun 23]. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59(6):366–78. Wong MCS, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955–66.e61. Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer. 2019;144(12):2992–3000. Zohrabyan D, Karapetyan N, Danielyan S, Saghatelyan T, Safaryan L, Bardakhchyan S, et al. Lung Cancer in Armenia. J Thor Onc. 2023;18(4):402–9. Baloyan E, Zohrabyan D, Safaryan L, Avagyan A, Harutyunyan L, Bardakhchyan V, et al. Treatment and Outcomes of Pancreatic Cancer in Armenia: A Retrospective Study From Resource-Limited Settings. JCO Glob Oncol. 2025;(11). Bardakhchyan S, Mkhitaryan S, Zohrabyan D, Safaryan L, Avagyan A, Harutyunyan L, et al. Treatment and Outcomes of Colorectal Cancer in Armenia: A Real-World Experience From a Developing Country. JCO Glob Oncol. 2020;(6):1286–97. Hricak H, Abdel-Wahab M, Atun R, Lette MM, Paez D, Brink JA, et al. Lancet Oncology Commission on medical imaging and nuclear medicine. Lancet Oncol. 2021;22(4):e136. Katsoula A, Paschos P, Haidich AB, Tsapas A, Giouleme O. Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis. JAMA Intern Med. 2017;177(8):1110–8. Doubeni CA, Corley DA, Jensen CD, Levin TR, Ghai NR, Cannavale K, et al. Fecal immunochemical test screening and risk of colorectal cancer death. JAMA Netw Open. 2024;7(7):e2423671. Zheng S, Schrijvers JJA, Greuter MJW, Kats-Ugurlu G, Lu W, de Bock GH. Effectiveness of colorectal cancer screening on all-cause and CRC-specific mortality reduction: a systematic review and meta-analysis. Cancers (Basel). 2023;15(7):1793. Nur AM, Aljunid SM, Tolma EL, Annaka M, Alwotayan R, Elbasmi A, et al. Cost effectiveness analysis of three colorectal cancer screening modalities in Kuwait. Sci Rep. 2025;15(1):22219. Mahmoud M, Parambil J, Danjuma M, Abubeker I, Najim M, Ghazouani H, et al. Knowledge, attitude and practice of physicians regarding screening of colorectal cancer in Qatar: a cross-sectional survey. Adv Med Educ Pract. 2020;11:843–50. Deeds S, Schuttner L, Wheat C, Gunnink E, Geyer J, Beste L, et al. Automated reminders enhance mailed fecal immunochemical test completion among veterans: a randomized controlled trial. J Gen Intern Med. 2024;39(1):113–9. Huang T, Qiu J, Wang C, Ma X, Liu D, Cai J. Trends and projections of early-onset colorectal cancer burden in China, 1990–2036: findings from the global burden of disease 2021 study. Cancer Control. 2025;32:10732748251341524. Amicizia D, Piazza MF, Grammatico F, Lavieri R, Marchini F, Astengo M, et al. Organizational determinants and outcomes related to participation and adherence to cancer public health screening: a systematic review. Cancers (Basel). 2025;17(11):1775. Gupta S, Nodora J. Optimizing the quality of the colorectal cancer screening continuum: a call to action. J Natl Cancer Inst. 2017;109(5):djw271. Hassan C, Spadaccini M, Iannone A, Maselli R, Jovani M, Chandrasekar VT, et al. Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(1):77-85.e6. Menke-van der Houven van Oordt CW, Gootjes EC, Huisman MC, Vugts DJ, Roth C, Luik AM, et al. 89Zr-cetuximab PET imaging in patients with advanced colorectal cancer. Oncotarget. 2015;6(30):30384-94. Lumish MA, Maron SB, Paroder V, Chou JF, Capanu M, Philemond S, et al. Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using 89Zr-trastuzumab PET: a pilot study. J Nucl Med. 2023;64(5):724–30. Manafi-Farid R, Ataeinia B, Ranjbar S, Jamshidi Araghi Z, Moradi MM, Pirich C, et al. ImmunoPET: antibody-based PET imaging in solid tumors. Front Med (Lausanne). 2022;9:916693. De Valk KS, Deken MM, Schaap DP, Meijer RP, Boogerd LS, Hoogstins CE, et al. Dose-finding study of a CEA-targeting agent, SGM-101, for intraoperative fluorescence imaging of colorectal cancer. Ann Surg Oncol. 2021;28(3):1832–44. Jiang J, Yuan C, Zhang J, Xie Z, Xiao J. Spectroscopic photoacoustic/ultrasound/optical-microscopic multimodal intrarectal endoscopy for detection of centimeter-scale deep lesions. Front Bioeng Biotechnol. 2023;11:1136005. Kumar V. Advances in artificial intelligence for oncology: a comprehensive review of techniques, challenges, and applications. In: 2025 Seventh International Conference on Computational Intelligence and Communication Technologies (CCICT); 2025;40–7. Sargsyan A, Hovsepyan S, Muradyan A. Ubiquitous and powerful artificial intelligence (AI). In: The Sustainable Development Goals Series. 2024;3373:255–71. Shiu KK, André T, Kim TW, Vittrup Jensen B, Jensen LH, Punt CJA, et al. Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up of the randomized phase III KEYNOTE-177 study. Ann Oncol. 2023;34(3):S1271–2. Andre T, Elez E, Van Cutsem E, Jensen LH, Bennouna J, Mendez G, et al. Nivolumab plus ipilimumab vs chemotherapy as first-line treatment for MSI-H/dMMR metastatic colorectal cancer: first results of the CheckMate 8HW study. J Clin Oncol. 2024;42(3):LBA768. Cercek A, Foote MB, Rousseau B, Smith JJ, Shia J, Sinopoli J, et al. Nonoperative management of mismatch repair-deficient tumors. N Engl J Med. 2025 Jun 19;392(23):2297–308 Dijkstra EA, Nilsson PJ, Hospers GAP, Bahadoer RR, Meershoek-Klein Kranenbarg E, Roodvoets AGH, et al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial. Ann Surg. 2023;278(4):E766–72. Tabernero J, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, et al. Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: updated survival results and subgroup analyses from the BEACON study. J Clin Oncol. 2021;39(4):273–84. Kopetz S, Bekaii-Saab TS, Yoshino T, Chung CH, Zhang X, Tabernero J. SEAMARK: randomized phase 2 study of pembrolizumab plus encorafenib plus cetuximab versus pembrolizumab alone for first-line treatment of BRAF V600E-mutant and MSI-H/dMMR metastatic colorectal cancer. J Clin Oncol. 2022 ;40:TPS3634. Bullock AJ, Schlechter BL, Fakih MG, Tsimberidou AM, Grossman JE, Gordon MS, et al. Botensilimab plus balstilimab in relapsed/refractory microsatellite-stable metastatic colorectal cancer: a phase 1 trial. Nat Med. 2024;30(9):2558–67. Pietrantonio F, Salvatore L, Esaki T, Modest DP, Lopez-Bravo DP, Taieb J, et al. Overall survival analysis of the phase III CodeBreaK 300 study of sotorasib plus panitumumab versus investigator’s choice in chemorefractory KRAS G12C colorectal cancer. J Clin Oncol. 2025 Jul;43(19):2147–54. André T, Van Cutsem E, Taieb J, Fakih M, Prager GW, Ciardiello F, et al. Clinical trial data review of the combination FTD/TPI plus bevacizumab in the treatment landscape of unresectable metastatic colorectal cancer. Curr Treat Options Oncol. 2024;25(10):1009–22. Huang HY, Liu CC, Yu Y, Wang L, Wu DW, Guo LW, et al. Pharmacoeconomic evaluation of cancer biosimilars worldwide: a systematic review. Front Pharmacol. 2020;11:572569. Eldridge L, Goodman NR, Chtourou A, Galassi A, Monge C, Cira K, et al. Barriers and opportunities for cancer clinical trials in low- and middle-income countries. JAMA Netw Open. 2025;8(4):e257733. Sargsyan A, Tamamyan G, Oganisian A, Zohrabyan D, Safaryan L, Avagyan A, et al. Nationwide insights on immunotherapy in a low- and middle-income country: Armenia’s struggle for equitable cancer care in an out-of-pocket system. JCO Glob Oncol. 2025;11:1–10. Xu W, Towers AD, Li P, Collet JP. Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care. 2006;15(4):397–403. Sun Q, He M, Zhang M, Zeng S, Chen L, Zhao H, et al. Traditional Chinese medicine and colorectal cancer: implications for drug discovery. Front Pharmacol. 2021;12:685002. Courneya KS, Vardy JL, O’Callaghan CJ, Gill S, Friedenreich CM, Wong RKS, et al; CHALLENGE Investigators. Structured exercise after adjuvant chemotherapy for colon cancer. N Engl J Med. 2025 Jul 3;393(1):13–25 China’s integrative medicine approach key to increased cancer survival – China Daily [Internet]. [cited 2025 Jun 23] Van Blarigan E, McKinley MA, Finster LJ, Cheng I, Gomez SL, Haile R. Incidence trends of early-onset colorectal cancer in the United States by age, sex, race and ethnicity, and urbanicity (2000–2021). J Clin Oncol. 2025;43(4):26. Mauri G, Patelli G, Crisafulli G, Siena S, Bardelli A. Tumor “age” in early-onset colorectal cancer. Cell. 2025;188(3):589–93. Shin A, Jung KW, Jeong SY. Right then, wrong now: early-onset colorectal cancer in Korea. Cancer Res Treat. 2023;55(3):1058–60. Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, et al. Rising incidence of early-onset colorectal cancer: a call for action. Nat Rev Clin Oncol. 2020;18(4):230–44. Raphael MJ. Early age onset colorectal cancer: a Canadian perspective. Can Oncol Today. 2024;1:22–9. Young JP, Win AK, Rosty C, Flight I, Roder D, Young GP, et al. Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review. J Gastroenterol Hepatol. 2015;30(1):6–13. Saraiva MR, Rosa I, Claro I. Early-onset colorectal cancer: a review of current knowledge. World J Gastroenterol. 2023;29(8):1289–305. Mannucci A, Hernández G, Uetake H, Yamada Y, Balaguer F, Baba H, et al. Prediction of long-term recurrence-free and overall survival in early-onset colorectal cancer: the ENCORE multicentre study. NPJ Precis Oncol. 2025;9(1):1–11. Song J, Han T, Qian L, Zhu J, Qiao Y, Liu S, et al. A decade-long study on pathological distinctions of resectable early versus late onset colorectal cancer and optimal screening age determination. Sci Rep. 2024;14(1):27335. Kang JHE, Jensen CD, Udaltsova N, Badalov JM, Fireman BH, Sakoda L, et al. Early-onset colorectal cancer survival by race and ethnicity in a large community-based insured population. Gastro Hep Adv. 2025;4(8):788–99. Hua H, Jiang Q, Sun P, Xu X. Risk factors for early-onset colorectal cancer: systematic review and meta-analysis. Front Oncol. 2023;13:1132306. Shiels MS, Haque AT, Berrington de González A, Camargo MC, Clarke MA, Davis Lynn BC, et al. Trends in cancer incidence and mortality rates in early-onset and older-onset age groups in the United States, 2010–2019. Cancer Discov. 2025;OF1–14. Memorial Sloan Kettering Cancer Center. MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer [Internet]. [cited 2025 Jun 23]. Dana-Farber Cancer Institute. Young-Onset Colorectal Cancer Center [Internet]. [cited 2025 Jun 23]. Bolwell J, Butler R, Burke CA, Liska D, Macaron C. Risk factors associated with advanced colorectal neoplasia in adults younger than age 45. J Clin Gastroenterol. 2024;58(9):882–8. Cercek A, Chatila WK, Yaeger R, Walch H, Fernandes GDS, Krishnan A, et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J Natl Cancer Inst. 2021;113(12):1683–92. Burnett-Hartman AN, Lee JK, Demb J, Gupta S. An update on the epidemiology, molecular characterization, diagnosis, and screening strategies for early-onset colorectal cancer. Gastroenterology. 2021;160(4):1041–9. Segarmurthy MV, Lim RBL, Yeat CL, Ong YX, Othman S, Taher SW, et al. Mapping palliative care availability and accessibility: a first step to eradicating access deserts in low- and middle-income settings. J Palliat Care. 2024;39(4):255–63. AlZaabi A, AlHarrasi A, AlMusalami A, AlMahyijari N, Al Hinai K, AlAdawi H, et al. Early onset colorectal cancer: challenges across the cancer care continuum. Ann Med Surg (Lond). 2022;82:104689. Baskar S, Lee B, Midha R, Grewal U. Impact of inpatient palliative care on end-of-life care among patients with early-onset colorectal cancer. J Clin Oncol. 2025;43(4):305. Fight Colorectal Cancer. Home | Fight CRC [Internet]. [cited 2025 Jun 23]. Colorectal Cancer Alliance. Prevention, support & research for colorectal cancer [Internet]. [cited 2025 Jun 23]. GI Cancers Alliance. Fight against gastrointestinal cancers [Internet]. [cited 2025 Jun 23]. COLONTOWN. About – COLONTOWN [Internet]. [cited 2025 Jun 23]. Global Colon Cancer Association. About Global Colon Cancer Association | GCCA [Internet]. [cited 2025 Jun 23]. Digestive Cancers Europe. Members – Digestive Cancers Europe [Internet]. [cited 2025 Jun 23]. Asia-Pacific Oncology Alliance. Asia-Pacific Oncology Alliance – ecancer [Internet]. [cited 2025 Jun 23]. Union for International Cancer Control (UICC). Patient group mentoring programme [Internet]. [cited 2025 Jun 23]. Odedina FT, Asante-Shongwe K, Kandusi EJ, Segal R, Pressey S, Reams RR, et al. The African Cancer Advocacy Consortium: shaping the path for advocacy in Africa. Infect Agent Cancer. 2013;8(1):S8 Romero Y, Tittenbrun Z, Trapani D, Given L, Hohman K, Cira MK, et al. The changing global landscape of national cancer control plans. Lancet Oncol. 2025;26(1):e46–54. Ghebreyesus TA, Mired D, Sullivan R, Mueller A, Charalambous A, Kacharian A, et al. A manifesto on improving cancer care in conflict-impacted populations. Lancet. 2024;404(10451):427–9. European Commission. EU Mission: Cancer – European Commission [Internet]. [cited 2025 Sep 19]. Al-Dahshan A, Abushaikha S, Chehab M, Bala M, Kehyayan V, Omer M, et al. Perceived barriers to colorectal cancer screening among eligible adults in Qatar and associated factors: a cross-sectional study. Asian Pac J Cancer Prev. 2021;22(1):45–52. European Regions Research and Innovation Network (ERRIN). ONCODIR: survey on primary prevention of colorectal cancer [Internet]. [cited 2025 Sep 19]. OncoScreen Project. Press release: On a mission to revolutionise CRC prevention and early detection – DIOPTRA and ONCOSCREEN Mission Cancer projects join forces [Internet]. [cited 2025 Sep 19]. ECHoS Cancer Mission Hubs. Why missions? A mission in health: the EU Cancer Mission [Internet]. [cited 2025 Sep 19].